BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22015647)

  • 1. Higher incidence of clear cell adenocarcinoma of the cervix and vagina among women born between 1947 and 1971 in the United States.
    Smith EK; White MC; Weir HK; Peipins LA; Thompson TD
    Cancer Causes Control; 2012 Jan; 23(1):207-11. PubMed ID: 22015647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up.
    Huo D; Anderson D; Palmer JR; Herbst AL
    Gynecol Oncol; 2017 Sep; 146(3):566-571. PubMed ID: 28689666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of clear-cell adenocarcinoma of the vagina and cervix among US women with potential exposure to diethylstilbestrol in utero.
    White MC; Weir HK; Soman AV; Peipins LA; Thompson TD
    Cancer Causes Control; 2022 Aug; 33(8):1121-1124. PubMed ID: 35767133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks.
    Hanselaar A; van Loosbroek M; Schuurbiers O; Helmerhorst T; Bulten J; Bernhelm J
    Cancer; 1997 Jun; 79(11):2229-36. PubMed ID: 9179071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late cervical and vaginal clear cell adenocarcinoma in women exposed in utero to diethylstilbestrol: Evaluation and screening.
    Tournaire M; Gondry J; Mauny L; Devouche E; Morice P
    J Gynecol Obstet Hum Reprod; 2023 Oct; 52(8):102630. PubMed ID: 37451413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic].
    van Dijck JA; Doorduijn Y; Bulten JH; Verloop J; Massuger LF; Kiemeney BA
    Ned Tijdschr Geneeskd; 2009; 153():A366. PubMed ID: 19857300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix.
    Herbst AL; Cole P; Colton T; Robboy SJ; Scully RE
    Am J Obstet Gynecol; 1977 May; 128(1):43-50. PubMed ID: 851158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol.
    Herbst AL; Anderson D
    Semin Surg Oncol; 1990; 6(6):343-6. PubMed ID: 2263810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer risk in DES daughters.
    Verloop J; van Leeuwen FE; Helmerhorst TJ; van Boven HH; Rookus MA
    Cancer Causes Control; 2010 Jul; 21(7):999-1007. PubMed ID: 20204493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer risk in women exposed to diethylstilbestrol in utero.
    Hatch EE; Palmer JR; Titus-Ernstoff L; Noller KL; Kaufman RH; Mittendorf R; Robboy SJ; Hyer M; Cowan CM; Adam E; Colton T; Hartge P; Hoover RN
    JAMA; 1998 Aug; 280(7):630-4. PubMed ID: 9718055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In utero exposure to DES. Evaluation and followup of 199 women.
    Fowler WC; Edelman DA
    Obstet Gynecol; 1978 Apr; 51(4):459-63. PubMed ID: 662229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six years' experience with screening of a diethylstilbestrol-exposed population.
    Mangan CE; Guintoli RL; Sedlacek TV; Rocereto T; Rubin E; Burtnett M; Mikuta JJ
    Am J Obstet Gynecol; 1979 Aug; 134(8):860-5. PubMed ID: 463989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects in the human of diethylstilbestrol (DES) use during pregnancy.
    Herbst AL
    Princess Takamatsu Symp; 1987; 18():67-75. PubMed ID: 3506546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear cell adenocarcinoma of the vagina and cervix: incidence, undetected disease, and diethylstilbestrol.
    Horwitz RI; Viscoli CM; Merino M; Brennan TA; Flannery JT; Robboy SJ
    J Clin Epidemiol; 1988; 41(6):593-7. PubMed ID: 3385459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of cervical intra-epithelial neoplasia and invasive cancer of the cervix in DES daughters.
    Verloop J; van Leeuwen FE; Helmerhorst TJM; de Kok IMCM; van Erp EJM; van Boven HH; Rookus MA
    Gynecol Oncol; 2017 Feb; 144(2):305-311. PubMed ID: 27939984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma.
    Waggoner SE; Mittendorf R; Biney N; Anderson D; Herbst AL
    Gynecol Oncol; 1994 Nov; 55(2):238-44. PubMed ID: 7959291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer risk in women prenatally exposed to diethylstilbestrol.
    Troisi R; Hatch EE; Titus-Ernstoff L; Hyer M; Palmer JR; Robboy SJ; Strohsnitter WC; Kaufman R; Herbst AL; Hoover RN
    Int J Cancer; 2007 Jul; 121(2):356-60. PubMed ID: 17390375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytologic examination to detect clear cell adenocarcinoma of the vagina or cervix.
    Hanselaar AG; Boss EA; Massuger LF; Bernheim JL
    Gynecol Oncol; 1999 Dec; 75(3):338-44. PubMed ID: 10600286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States).
    Hatch EE; Herbst AL; Hoover RN; Noller KL; Adam E; Kaufman RH; Palmer JR; Titus-Ernstoff L; Hyer M; Hartge P; Robboy SJ
    Cancer Causes Control; 2001 Nov; 12(9):837-45. PubMed ID: 11714112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [DES Daughter--expertise remains necessary].
    Verheijen RH; Verloop J; Helmerhorst TJ
    Ned Tijdschr Geneeskd; 2013; 157(52):A6809. PubMed ID: 24382040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.